The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis
Open accessAbstract
BACKGROUND: Identification of variable epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer (NSCLC) is important for the selection of appropriate targeted therapies. This meta-analysis was conducted to provide a worldwide overview of EGFR mutation and submutation (specifically exon 19 deletions, exon 21 L858R substitutions, and others) prevalence, and identify important covariates that influence EGFR mutation status in patients with advanced NSCLC to address this clinical data gap. METHODS: in Ovid were searched for studies published between 2004 and 2019 with cohorts of ≥ 50 adults with EGFR mutations, focusing on stage III/IV NSCLC (≤ 20% of patients with stage I/II NSCLC). Linear mixed-effects models were fitted to EGFR mutation endpoints using logistic transformation (logit), assuming a binomial distribution. The model included terms for an intercept reflecting European studies and further additive terms for other continents. EGFR submutations examined were exon 19 deletions, exon 21 L858R substitutions, and others. RESULTS: Of 3969 abstracts screened, 57 studies were included in the overall EGFR mutation analysis and 74 were included in the submutation analysis relative to the overall EGFR mutation population (Europe, n = 12; Asia, n = 51; North America, n = 5; Central America, n = 1; South America, n = 1; Oceania, n = 1; Global, n = 3). The final overall EGFR mutations model estimated Asian and European prevalence of 49.1% and 12.8%, respectively, and included an additive covariate for the proportion of male patients in a study. There were no significant covariates in the submutation analyses. Most submutations were actionable: exon 19 deletions (49.2% [Asia]; 48.4% [Europe]); exon 21 L858R substitutions (41.1% [Asia]; 29.9% [Europe]). CONCLUSIONS: Although EGFR mutation prevalence was higher in Asian than Western countries, data support worldwide testing for EGFR overall and submutations to inform appropriate targeted treatment decisions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fitting Linear Mixed-Effects Models Using lme4
Bates, D., Mächler, M., Bolker, B., & Walker, S. (2015) · Journal of Statistical Software · doi:10.18637/jss.v067.i01 · Cited by 86,835
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
Schiller, J. H., Harrington, D., Belani, C. P., Langer, C., Sandler, A., Krook, J., Zhu, J., & Johnson, D. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011954 · Cited by 4,955
COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
Chiller, J. O. H. S., Arrington, D. A. H., Elani, C. H. P. B., Anger, C., Andler, A. L. S., Rook, J. A. K., Hu, J., & Ohnson, D. A. H. J. (2002) · Cited by 3,730
Epidermal growth factor receptor mutations in lung cancer
Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170
Shigematsu, H., Lin, L., Takahashi, T., Nomura, M., Suzuki, M., Wistuba, I. I., Fong, K. M., Lee, H., Toyooka, S., Shimizu, N., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji055 · Cited by 2,377
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
Howlader, N., Forjaz, G., Mooradian, M. J., Meza, R., Kong, C. Y., Cronin, K. A., Mariotto, A. B., Lowy, D. R., & Feuer, E. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916623 · Cited by 1,712
Shi, Y., Au, J. S.-K., Thongprasert, S., Srinivasan, S., Tsai, C.-M., Khoa, M. T., Heeroma, K., Itoh, Y., Cornelio, G., & Yang, P.-C. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000033 · Cited by 1,551
Review of epidermal growth factor receptor biology
Herbst, R. S. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.041 · Cited by 1,390
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318290868f · Cited by 1,280
Midha, A., Dearden, S. P., & McCormack, R. (2015) · Europe PMC (PubMed Central) · Cited by 1,050
Economic burden of cancer across the European Union: a population-based cost analysis
Luengo-Fernandez, R., Leal, J., Gray, A., & Sullivan, R. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70442-x · Cited by 1,008
Zhang, Y.-L., Yuan, J.-Q., Wang, K.-F., Fu, X.-H., Han, X.-R., Threapleton, D., Yang, Z.-Y., Mao, C., & Tang, J.-L. (2016) · Oncotarget · doi:10.18632/oncotarget.12587 · Cited by 799
Dearden, S., Stevens, J., Wu, Y.-L., & Blowers, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt205 · Cited by 646
Lindeman, N. I., Cagle, P. T., Aisner, D. L., Arcila, M. E., Beasley, M. B., Bernicker, E. H., Colasacco, C., Dacic, S., Hirsch, F. R., Kerr, K., et al. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.12.001 · Cited by 645
Jordan, E. J., Kim, H. R., Arcila, M. E., Barron, D., Chakravarty, D., Gao, J., Chang, M. T., Ni, A., Kundra, R., Jonsson, P., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1337 · Cited by 643
Ohe, Y., Ohashi, Y., Kubota, K., Tamura, T., Nakagawa, K., Negoro, S., Nishiwaki, Y., Saijo, N., Ariyoshi, Y., & Fukuoka, M. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl377 · Cited by 633
New and emerging targeted treatments in advanced non-small-cell lung cancer
Hirsch, F. R., Suda, K., Wiens, J., & Bunn, P. A. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31473-8 · Cited by 487
Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., Jenkins, R. B., Kwiatkowski, D. J., Saldivar, J.-S., Squire, J., et al. (2013) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2012-0720-oa · Cited by 426
Shi, Y., Zhang, L., Liu, X., Zhou, C., Zhang, L., Zhang, S., Wang, D., Li, Q., Qin, S., Hu, C., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70355-3 · Cited by 422
Yang, J. C.-H., Shih, J.-Y., Su, W.-C., Hsia, T.-C., Tsai, C.-M., Ou, S.-H. I., Yu, C.-J., Chang, G.-C., Ho, C.-L., Sequist, L. V., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70086-4 · Cited by 410
Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973–2010
Meza, R., Meernik, C., Jeon, J., & Cote, M. L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121323 · Cited by 363
Kerr, K. M., Bubendorf, L., Edelman, M. J., Marchetti, A., Mok, T., Novello, S., O'Byrne, K., Stahel, R., Peters, S., Felip, E., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu145 · Cited by 298
Villalobos, P., & Wistuba, I. I. (2017) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2016.08.006 · Cited by 254
Tang, Y., Fang, W., Zhang, Y., Hong, S., Kang, S., Yan, Y., Chen, N., Zhan, J., He, X., Qin, T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3694 · Cited by 243
Yang, C.-H., Yu, C.-J., Shih, J.-Y., Chang, Y.-C., Hu, F.-C., Tsai, M.-C., Chen, K.-Y., Lin, Z.-Z., Huang, C.-J., Shun, C.-T., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6695 · Cited by 235
Park, K., Yu, C.-J., Kim, S.-W., Lin, M.-C., Sriuranpong, V., Tsai, C.-M., Lee, J.-S., Kang, J.-H., Chan, K. C. A., Perez-Moreno, P., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.4921 · Cited by 229
Shi, Y., Li, J., Zhang, S., Wang, M., Yang, S., Li, N., Wu, G., Liu, W., Liao, G., Cai, K., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143515 · Cited by 197
When is Cancer Care Cost-Effective? A Systematic Overview of Cost–Utility Analyses in Oncology
Greenberg, D., Earle, C., Fang, C.-H., Eldar-Lissai, A., & Neumann, P. J. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp472 · Cited by 183
Pinto, J. A., Vallejos, C. S., Raez, L. E., Mas, L. A., Ruiz, R., Torres-Roman, J. S., Morante, Z., Araujo, J. M., Gómez, H. L., Aguilar, A., et al. (2018) · ESMO Open · doi:10.1136/esmoopen-2018-000344 · Cited by 164
Faulkner, E., Annemans, L., Garrison, L., Helfand, M., Holtorf, A.-P., Hornberger, J., Hughes, D., Li, T., Malone, D., Payne, K., et al. (2012) · Value in Health · doi:10.1016/j.jval.2012.05.006 · Cited by 161
Gahr, S., Stoehr, R., Geissinger, E., Ficker, J. H., Brueckl, W. M., Gschwendtner, A., Gattenloehner, S., Fuchs, F. S., Schulz, C. K. J., Rieker, R. J., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.511 · Cited by 155
Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice
Aggarwal, C., Rolfo, C. D., Oxnard, G. R., Gray, J. E., Sholl, L. M., & Gandara, D. R. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0423-x · Cited by 155
Tissue and Blood Biomarkers in Lung Cancer: A Review
Duffy, M. J., & O'Byrne, K. J. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.05.001 · Cited by 135
Smits, A. J. J., Kummer, J. A., Hinrichs, J. W. J., Herder, G. J. M., Scheidel, K. C., Jiwa, N. M., Ruijter, T. E. G., Nooijen, P. T. G. A., Looijen-Salamon, M. G., Ligtenberg, M. J. L., et al. (2012) · Cellular Oncology · doi:10.1007/s13402-012-0078-4 · Cited by 128
Steuer, C. E., Behera, M., Berry, L. D., Kim, S., Rossi, M. R., Sica, G., Owonikoko, T. K., Johnson, B. E., Kris, M. G., Bunn, P. A., et al. (2015) · Cancer · doi:10.1002/cncr.29812 · Cited by 121
The Introduction of Systematic Genomic Testing for Patients with Non–Small-Cell Lung Cancer
Cardarella, S., Ortiz, T. M., Joshi, V. A., Butaney, M., Jackman, D. M., Kwiatkowski, D. J., Yeap, B. Y., Janne, P. A., Lindeman, N. I., & Johnson, B. E. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182745bcb · Cited by 116
Screening for EGFR mutations in lung cancer, a report from India
Sahoo, R., Harini, V. V., Babu, V. C., Okaly, G. V. P., Rao, S., Nargund, A. R., Venkataswamy, E., Rao, R., & Kumar, B. S. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.01.004 · Cited by 116
Shen, Y.-C., Tseng, G.-C., Tu, C.-Y., Chen, W.-C., Liao, W.-C., Chen, W.-C., Li, C.-H., Chen, H.-J., & Hsia, T.-C. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.06.007 · Cited by 99
Zhao, M., Zhang, Y., Cai, W., Li, J., Zhou, F., Cheng, N., Ren, R., Zhao, C., Li, X., Ren, S., et al. (2014) · Cancer · doi:10.1002/cncr.28725 · Cited by 92
Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung Cancer
Sun, J., Hwang, D. W., Ahn, J. S., Ahn, M., & Park, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064816 · Cited by 91
Pi, C., Xu, C., Zhang, M., Peng, X., Wei, X., Gao, X., Yan, H., & Zhou, Q. H. (2018) · Thoracic Cancer · doi:10.1111/1759-7714.12651 · Cited by 83
Evans, M., O’Sullivan, B., Hughes, F., Mullis, T., Smith, M. R., Trim, N., & Tanière, P. (2018) · Pathology & Oncology Research · doi:10.1007/s12253-018-0469-6 · Cited by 82
Choi, Y., Sun, J., Cho, J., Rampal, S., Han, J., Parasuraman, B. M., Güallar, E., Lee, G., Lee, J., & Shim, Y. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056011 · Cited by 79
Kuijpers, C. C. H. J., Hendriks, L. E. L., Derks, J. L., Dingemans, A. C., van Lindert, A. S. R., van den Heuvel, M. M., Damhuis, R. A. M., & Willems, S. M. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.05.006 · Cited by 73
Fujimoto, D., Ueda, H., Shimizu, R., Kato, R., Otoshi, T., Kawamura, T., Tamai, K., Shibata, Y., Matsumoto, T., Nagata, K., et al. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9648-3 · Cited by 62
Tumor biomarker testing in non-small-cell lung cancer: A decade of change
VanderLaan, P. A., Rangachari, D., Majid, A., Parikh, M. S., Gangadharan, S. P., Kent, M. S., McDonald, D. C., Huberman, M. S., Kobayashi, S. S., & Costa, D. B. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.01.002 · Cited by 62
Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas
Jin, Y., Shi, X., Zhao, J., He, Q., Chen, M., Yan, J., Ou, Q., Wu, X., Shao, Y. W., & Yu, X. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.07.039 · Cited by 62
Ramalingam, S. S., O'Byrne, K. J., Boyer, M. J., Mok, T. S. K., Janne, P. A., Zhang, H., Liang, J., Taylor, I., Sbar, E. I., & Paz-Ares, L. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv593 · Cited by 60
Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease
Campos-Parra, A. D., Avilés, A., Contreras-Reyes, S., Rojas-Marín, C. E., Sánchez-Reyes, R., Borbolla-Escoboza, R. J., & Arrieta, O. G. (2014) · European Respiratory Journal · doi:10.1183/09031936.00138813 · Cited by 59
Baek, M. Y., Ahn, H. K., Park, K. R., Park, H.-S., Kang, S. M., Park, I., Kim, Y. S., Hong, J., Sym, S. J., Park, J., et al. (2016) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2015.158 · Cited by 56
Jiang, T., Cheng, R., Zhang, G., Su, C., Zhao, C., Li, X., Zhang, J., Wu, F., Chen, X., Gao, G., et al. (2017) · Clinical Lung Cancer · doi:10.1016/j.cllc.2017.04.015 · Cited by 54
Chung, K., Huang, Y., Chang, Y., Yu, C., Yang, C.-H., Chang, Y., Shih, J., & Yang, P. (2011) · CHEST Journal · doi:10.1378/chest.10-3149 · Cited by 52
Hu, X., Han, B., Gu, A., Zhang, Y., Jiao, S., Wang, C.-L., He, J., Jia, X., Zhang, L., Peng, J., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.08.014 · Cited by 52
EGFR mutations in non‐small‐cell lung cancer among smokers and non‐smokers: A meta‐analysis
Ren, J., He, W., Yan, G., Jin, M., Yang, K., & Wu, G. (2011) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20680 · Cited by 51
Ellis, P. M., Verma, S., Sehdev, S. R., Younus, J., & Leighl, N. B. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31829f6a43 · Cited by 51
Yang, J. C., Kang, J. H., Mok, T. S. K., Ahn, M., Srimuninnimit, V., Lin, C., Kim, D., Tsai, C., Barraclough, H., Altuǧ, S., et al. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.05.011 · Cited by 50
Wang, S., Han, X., Hu, X., Wang, X., Zhao, L., Tang, L., Feng, Y., Wu, D., Sun, Y. P., & Shi, Y. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.12.026 · Cited by 49
Szumera‐Ciećkiewicz, A., Olszewski, W. T., Tysarowski, A., Kowalski, D. M., Głogowski, M., Krzakowski, M. J., SIEDLECKI, J. A., Wągrodzki, M., & Prochorec‐Sobieszek, M. (2013) · Europe PMC (PubMed Central) · Cited by 46
Locatelli-Sanchez, M., Couraud, S., Arpin, D., Riou, R., Bringuier, P., & Souquet, P.-J. (2013) · Lung · doi:10.1007/s00408-013-9482-4 · Cited by 45
Weber, B., Hager, H., Sørensen, B. S., McCulloch, T., Mellemgaard, A., Khalil, A. A., Nexø, E., & Meldgaard, P. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.11.023 · Cited by 45
Scagliotti, G. V., Shuster, D. E., Орлов, С. В., von Pawel, J., Shepherd, F. A., Ross, J. S., Wang, Q., Schwartz, B. E., & Akerley, W. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.12.009 · Cited by 44
Wang, B.-X., Ou, W., Mao, X., Liu, Z., Wu, H.-Q., & Wang, S. (2017) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2017.06.022 · Cited by 43
Schuette, W., Schirmacher, P., Eberhardt, W., Fischer, J. R., von der Schulenburg, J.-M. G., Mezger, J., Schumann, C., Serke, M. H., Zaun, S., Dietel, M., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1149 · Cited by 38
Salto‐Tellez, M., Tsao, M., Shih, J., Thongprasert, S., Lü, S., Chang, G., Au, J. S. K., Chou, T., Lee, J. S., Shi, Y.-K., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318227816a · Cited by 38
Cheng, Y., Wang, Y., Zhao, J., Liu, Y., Gao, H., Ma, K., Zhang, S., Xin, H., Liu, J., Han, C., et al. (2018) · Thoracic Cancer · doi:10.1111/1759-7714.12859 · Cited by 38
He, Y., Zhang, X., Yang, J., Niu, F., Zeng, Z., Yan, H., Xu, C., Guan, J.-L., Zhong, W., Yang, L., et al. (2014) · Clinical Lung Cancer · doi:10.1016/j.cllc.2014.06.006 · Cited by 37
Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma in Malaysian Patients
Liam, C. K., Wahid, M. I. A., Rajadurai, P., Cheah, Y. K., & Ng, T. S. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31828b5228 · Cited by 37
Ruíz-Patiño, A., Castro, C. D., Ricaurte, L., Cardona, A. F., Rojas, L., Zatarain-Barrón, Z. L., Wills, B., Reguart, N., Carranza, H., Vargas, C. A., et al. (2018) · Targeted Oncology · doi:10.1007/s11523-018-0594-x · Cited by 37
Li, B., Sun, S., Yang, M., Shi, J., Xu, W. D., Wang, X.-F., Song, M., & Chen, H.-M. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1776-3 · Cited by 35
John, A. K., Shah, R. A., Wong, W. B., Schneider, C. E., & Alexander, M. (2020) · The Oncologist · doi:10.1634/theoncologist.2019-0864 · Cited by 32
Wang, S., & Wang, Z. (2014) · Europe PMC (PubMed Central) · Cited by 31
Ramlau, R., Čufer, T., Berzinec, P., Dziadziuszko, R., Olszewski, W., Popper, H., Bajčić, P., Dusšk, L., Zbožínková, Z., & Pirker, R. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000621 · Cited by 31
Zhang, G., Cheng, R., Zhang, Z., Jiang, T., Ren, S., Ma, Z., Zhao, S., Zhou, C., & Zhang, J. (2017) · Scientific Reports · doi:10.1038/srep42979 · Cited by 31
Li, Y., Xu, H., Su, S., Ye, J., Chen, J., Jin, X., Lin, Q. D., Zhang, D., Ye, C., & Chen, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183331 · Cited by 31
Zhang, B., Wang, S., Qian, J., Yang, W., Qian, F., Lü, J., Zhang, Y., Qiao, R., & Han, B. (2018) · Cancer · doi:10.1002/cncr.31329 · Cited by 31
Vigneswaran, J., Tan, Y. C., Murgu, S. D., Won, B. M., Patton, K. A., Villaflor, V. M., Hoffman, P. C., Hensing, T. A., Hogarth, D. K., Malik, R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7739 · Cited by 30
Lung Cancer Disparities in Hispanics: Molecular Diagnosis and Use of Immunotherapy
Raez, L. E., Cardona, A. F., Arrieta, O. G., & Junior, G. L. L. (2020) · JCO Global Oncology · doi:10.1200/go.20.00004 · Cited by 27
EGFR mutations as a predictive marker of cytotoxic chemotherapy
Park, J. H., Lee, S., Keam, B., Kim, T. M., Kim, D., Yang, S.-C., Kim, Y. W., & Heo, D. S. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2012.03.020 · Cited by 25
Lu, R., Hu, C., Yang, H., Li, Y., Gu, Q., & Wu, L. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9715-0 · Cited by 25
Li, H., Wang, G., Zhang, H., Song, X., Cao, J., Zhang, X., Xue, R., Wang, W., Jia, S., & Li, Z. (2018) · Genes and Immunity · doi:10.1038/s41435-018-0050-z · Cited by 24
Buonerba, C., Iaccarino, S., Dolce, P., Pagliuca, M., Izzo, M., Scafuri, L., Costabile, F., Riccio, V., Ribera, D., Mucci, B., et al. (2019) · Cancers · doi:10.3390/cancers11091259 · Cited by 24
Dong, X., Zhao, X., Hao, Y., Wei, Y., Qiuwei, Y., & Du, J. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.05.004 · Cited by 21
Wang, Z., Fang, S., Guo, J., Liu, J., Li, C., Liu, L., Shi, H., Liu, L., Li, H., Xie, C. L., et al. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s63665 · Cited by 21
Lee, D.-W., Shin, D., Kim, J. W., Keam, B., Kim, T. M., Kim, H. J., Kim, D., Wu, H.-G., Paek, S. H., Kim, Y. W., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.10.001 · Cited by 21
Yang, R., Yu, B.-C., Zhang, R. Q., Wang, X. H., Li, C., Wang, P., Zhang, Y., Han, B., Gao, X. X., Zhang, L., et al. (2017) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20176073 · Cited by 18
Zhang, P., Nie, X., Bie, Z., & Li, L. (2018) · Medicine · doi:10.1097/md.0000000000010006 · Cited by 17
Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain
Arriola, E., Gómez, R. G., Díz, P., Majem, M., Aguillo, M. M., Valdivia, J., Paredes, A., Sánchez-Torres, J. M., Muñoz, S. P., Barneto, I., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4004-7 · Cited by 17
McKeage, M. J., Elwood, M., Tin, S. T., Khwaounjoo, P., Aye, P. S., Li, A., Sheath, K. L., Shepherd, P., Laking, G. R., Kingston, N. J., et al. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0515-4 · Cited by 16
Ku, B. M., Heo, M. H., Kim, J.-H., Cho, B. C., Cho, E. K., Min, Y. J., Lee, K. H., Sun, J., Lee, S., Ahn, J. S., et al. (2018) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2018.03.12 · Cited by 16
Effects of Icotinib on Advanced Non-Small Cell Lung Cancer with Different EGFR Phenotypes
Pan, H., Liu, R., Li, S., Fang, H., Wang, Z., Huang, S., & Zhou, J. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-9955-y · Cited by 15
CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation
Zhao, J., Dinkel, J., Warth, A., Penzel, R., Reinmuth, N., Schnabel, P. A., Muley, T., Meister, M. A., Zabeck, H., Steins, M. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182741 · Cited by 14
Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients
Bichev, S., Marinova, D., Slavova, Y. G., & Savov, A. S. (2014) · Cellular Oncology · doi:10.1007/s13402-014-0211-7 · Cited by 11
Sun, J., Rampal, S., Lee, G., Lee, J., Choi, Y., Parasuraman, B. M., Güallar, E., Cho, J., & Shim, Y. M. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.01.009 · Cited by 11
Han, X., Zhang, Z., Wu, D., Shen, Y., Wang, S., Wang, L., Liu, Y., Yang, S., Hu, X., Feng, Y., et al. (2014) · Translational Oncology · doi:10.1016/j.tranon.2014.10.008 · Cited by 10
Tseng, Y.-H., Tseng, Y., Lin, Y.-H., Lee, Y.-C., Perng, R.-P., Whang‐Peng, J., & Chen, Y.-M. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0352 · Cited by 8
Coloma, C. S., Lorente, D., Palanca, S., Simarro, J., Mancheño, N., Sandoval, J., Lahoz, A., & Juan, Ó. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.02.30 · Cited by 8
Paliwal, P., Rajappa, S. J., Ayyagari, S., Mohan, M. V. T. K., Murthy, S., & Lavanya, N. (2017) · Indian Journal of Cancer · doi:10.4103/0019-509x.219595 · Cited by 7
Matsumura, Y., Owada, Y., Inoue, T., Watanabe, Y., Yamaura, T., Fukuhara, M., Muto, S., Okabe, N., Hasegawa, T., Hoshino, M., et al. (2017) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivx207 · Cited by 5
Togashi, Y., Masago, K., Kubo, T., Fujimoto, D., Sakamori, Y., Nagai, H., Kim, Y. H., Togashi, K., & Mishima, M. (2012) · Medical Oncology · doi:10.1007/s12032-012-0235-7 · Cited by 4
Cited by
Fang, W., Li, X., Wang, Q., Meng, X., Zheng, W., Sun, L., Yao, W., Zhuang, W., Fan, Y., Zhuo, M., et al. (2025) · BMJ · doi:10.1136/bmj-2025-085680 · Cited by 51
Metadata
- Authors
- Melosky, B., Kambartel, K., Häntschel, M., Bennetts, M., Nickens, D. J., Brinkmann, J., Kayser, A., Moran, M., & Cappuzzo, F.
- Venue
- Molecular Diagnosis & Therapy
- Published
- 2021-11-23
- Volume
- 26
- Issue
- 1
- Pages
- 7-18
- ISSN
- 1177-1062 (ISSN-L)
- 1179-2000
- OpenAlex
- W3214907506
- Cited by
- 255
- References
- 104
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.